Investment management groups, including
Stephens,
Nordea,
Campbell & CO, among others, have shown an increasing interest in
PTC Inc. stocks, which have been outperforming Oracle in terms of both price and potential. Although
recent share price dips and
tech volatility have brought about concerns in valuation, Wall Street Zen upgraded PTC's stock rating, suggesting
resiliency. There has also been insider selling from executives at both PTC and PTC Therapeutics, with Rep. April McClain Delaney, Eric Pauwels, Mark Elliot Boulding, and others selling shares. However,
2026 revenue guidance from PTC Inc. and PTCT has reshaped market expectations, giving new light on the stock's value. Both PTC Inc. and PTCT have also released FY 2026 Earnings Guidance. PTC Inc. has also made headlines with its initiative to
expand partnerships and
divest non-core units while maintaining confidence in AR growth. Despite recent drops in the stock's price, PTC Inc. is still considered a top growth stock for the long term by market watchers.
PTC Stocks News Analytics from Wed, 18 Jun 2025 07:00:00 GMT to Sat, 17 Jan 2026 12:05:47 GMT -
Rating 5
- Innovation 2
- Information 9
- Rumor 4
